Forte Biosciences, Inc. (FBRX)
NASDAQ · Healthcare
Forte Biosciences, Inc. Total Liabilities 2016–2019
Forte Biosciences, Inc. annual/quarterly total liabilities history from 2016 to 2019. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Forte Biosciences, Inc. total liabilities for the quarter ending December 31, 2019 were 17.3M, a 61.47% decrease year-over-year.
- Forte Biosciences, Inc. total liabilities for 2019 were 17.3M, a 61.47% decrease from 2018.
- Forte Biosciences, Inc. total liabilities for 2018 were 44.9M, a 114.07% increase from 2017.
- Forte Biosciences, Inc. total liabilities for 2017 were 21.0M, a 25.97% decrease from 2016.
- Forte Biosciences, Inc. total liabilities for 2016 were 28.4M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Forte Biosciences, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2019 | $17 |
| 2018 | $45 |
| 2017 | $21 |
| 2016 | $28 |
| Forte Biosciences, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2019-12-31 | $17 |
| 2018-12-31 | $45 |
| 2017-12-31 | $21 |
| 2016-12-31 | $28 |
Forte Biosciences, Inc. Total Liabilities — FAQ
Forte Biosciences, Inc. (FBRX) total liabilities over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see FBRX's total liabilities history?
The chart and table above show Forte Biosciences, Inc.'s total liabilities by year and by quarter, including the growth rate.